stockrowRegeneron Pharmaceuticals, Inc. (REGN) vs Revolution Medicines, Inc. (RVMD)
- Regeneron Pharmaceuticals, Inc. REGN 907.36 +0.49%
- Revolution Medicines, Inc. RVMD 192.27 +8.23%
Regeneron Pharmaceuticals, Inc. and Revolution Medicines, Inc. are both Biotechnology companies. Regeneron Pharmaceuticals, Inc. is the larger, with a market value of $93.4B against $38.1B — 2.5× the size. Revolution Medicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Regeneron Pharmaceuticals, Inc. trades at 19.2×. Revolution Medicines, Inc. grew revenue faster over the last twelve months: 491.1% against 18.6%. Regeneron Pharmaceuticals, Inc. has the higher net margin (28.5% vs −894.4%) and the higher return on invested capital (11.6% vs 0.00%). Across the 19 metrics below, Regeneron Pharmaceuticals, Inc. leads on 15 and Revolution Medicines, Inc. on 4.
Valuation
Profitability
| Metric | REGN | RVMD | Biotechnology median |
|---|---|---|---|
| Gross margin | 85.77% | 95.62% | 65.16% |
| Operating margin | 28.79% | (805.75%) | 0.00% |
| Net margin | 28.51% | (894.40%) | 0.00% |
| Free cash flow margin | 21.47% | (688.93%) | 0.00% |
| Return on equity | 14.95% | (93.56%) | (50.12%) |
| Return on assets | 11.39% | (57.07%) | (45.60%) |
| Return on invested capital | 11.61% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack